Nathani A, Aare M, Sun L, Bagde A, Li Y, Rishi A
Pharmaceutics. 2024; 16(8.
PMID: 39204415
PMC: 11359469.
DOI: 10.3390/pharmaceutics16081070.
Schnell A, Huang L, Regan B, Singh V, Vonficht D, Bollhagen A
Nat Immunol. 2023; 24(11):1908-1920.
PMID: 37828379
PMC: 10864036.
DOI: 10.1038/s41590-023-01645-4.
Yurkina D, Sharapova T, Romanova E, Yashin D, Sashchenko L
Int J Mol Sci. 2023; 24(14).
PMID: 37511122
PMC: 10379010.
DOI: 10.3390/ijms241411363.
Ivanova O, Sharapova T, Romanova E, Sashchenko L, Yashin D, Georgiev G
Dokl Biochem Biophys. 2022; 506(1):181-184.
PMID: 36303048
PMC: 9613720.
DOI: 10.1134/S1607672922050064.
Jurgec S, Jezernik G, Gorenjak M, Budefeld T, Potocnik U
Cancers (Basel). 2022; 14(19).
PMID: 36230605
PMC: 9562668.
DOI: 10.3390/cancers14194681.
N-Terminal Peptide of PGLYRP1/Tag7 Is a Novel Ligand for TREM-1 Receptor.
Sharapova T, Ivanova O, Romanova E, Sashchenko L, Yashin D
Int J Mol Sci. 2022; 23(10).
PMID: 35628562
PMC: 9144885.
DOI: 10.3390/ijms23105752.
The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab.
Chang Z, Dang T, Meng X, Chai J
Cancer Control. 2022; 29:10732748221074734.
PMID: 35291889
PMC: 8935545.
DOI: 10.1177/10732748221074734.
Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse Alveolar Damage of Lung through Blockage of the TREM-1 and TNFR1 Receptors.
Sharapova T, Romanova E, Chernov A, Minakov A, Kazakov V, Kudriaeva A
Int J Mol Sci. 2021; 22(20).
PMID: 34681871
PMC: 8538247.
DOI: 10.3390/ijms222011213.
Hsp70 Interacts with the TREM-1 Receptor Expressed on Monocytes and Thereby Stimulates Generation of Cytotoxic Lymphocytes Active against MHC-Negative Tumor Cells.
Sharapova T, Romanova E, Ivanova O, Yashin D, Sashchenko L
Int J Mol Sci. 2021; 22(13).
PMID: 34206968
PMC: 8267615.
DOI: 10.3390/ijms22136889.
A 8-mer Peptide of PGLYRP1/Tag7 Innate Immunity Protein Binds to TNFR1 Receptor and Inhibits TNFα-Induced Cytotoxic Effect and Inflammation.
Telegin G, Chernov A, Kazakov V, Romanova E, Sharapova T, Yashin D
Front Immunol. 2021; 12:622471.
PMID: 34163464
PMC: 8215708.
DOI: 10.3389/fimmu.2021.622471.
Mechanisms of Action of the PGLYRP1/Tag7 Protein in Innate and Acquired Immunity.
Yashin D, Sashchenko L, Georgiev G
Acta Naturae. 2021; 13(1):91-101.
PMID: 33959389
PMC: 8084298.
DOI: 10.32607/actanaturae.11102.
Cytokines TNFα, IFNγ and IL-2 Are Responsible for Signal Transmission from the Innate Immunity Protein Tag7 (PGLYRP1) to Cytotoxic Effector Lymphocytes.
Sharapova T, Romanova E, Ivanova O, Sashchenko L, Yashin D
Cells. 2020; 9(12).
PMID: 33291689
PMC: 7761954.
DOI: 10.3390/cells9122602.
HSP70 Multi-Functionality in Cancer.
Albakova Z, Armeev G, Kanevskiy L, Kovalenko E, Sapozhnikov A
Cells. 2020; 9(3).
PMID: 32121660
PMC: 7140411.
DOI: 10.3390/cells9030587.
A 12-mer Peptide of Tag7 (PGLYRP1) Forms a Cytotoxic Complex with Hsp70 and Inhibits TNF-Alpha Induced Cell Death.
Romanova E, Sharapova T, Telegin G, Minakov A, Chernov A, Ivanova O
Cells. 2020; 9(2).
PMID: 32093269
PMC: 7072780.
DOI: 10.3390/cells9020488.
Urinary peptide panel for prognostic assessment of bladder cancer relapse.
Krochmal M, van Kessel K, Zwarthoff E, Belczacka I, Pejchinovski M, Vlahou A
Sci Rep. 2019; 9(1):7635.
PMID: 31114012
PMC: 6529475.
DOI: 10.1038/s41598-019-44129-y.
Innate Immune Protein Tag7 Stimulates the Appearance of Cytotoxic NK Cells after Incubation with Lymphocytes.
Sharapova T, Romanova E, Sashchenko L, Gnuchev N, Yashin D
Dokl Biochem Biophys. 2019; 484(1):92-94.
PMID: 31012024
DOI: 10.1134/S1607672919010253.
Tag7-Mts1 Complex Induces Lymphocytes Migration via CCR5 and CXCR3 Receptors.
Sharapova T, Romanova E, Sashchenko L, Yashin D
Acta Naturae. 2019; 10(4):115-120.
PMID: 30713770
PMC: 6351033.
A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells.
Sapozhnikov A, Klinkova A, Shustova O, Grechikhina M, Kilyachus M, Stremovskiy O
Acta Naturae. 2018; 10(3):85-91.
PMID: 30397532
PMC: 6209404.
Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity.
Sharapova T, Romanova E, Sashchenko L, Yashin D
J Immunol Res. 2018; 2018:4501273.
PMID: 29850628
PMC: 5925135.
DOI: 10.1155/2018/4501273.
The role of S100A4 protein in anticancer cytotoxicity: its presence is required on the surface of CDCDPGRPsS100A4 lymphocyte and undesirable on the surface of target cells.
Dukhanina E, Lukyanova T, Dukhanin A, Georgieva S
Cell Cycle. 2017; 17(4):479-485.
PMID: 29251175
PMC: 5927690.
DOI: 10.1080/15384101.2017.1415678.